Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma, Malignant × Sorafenib × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 49 Carcinoma, Renal Cell 23 Liver Neoplasms 22 Neoplasms 18 Breast Neoplasms 15 Carcinoma, Non-Small-Cell Lung 14 Kidney Neoplasms 10 Leukemia, Myeloid, Acute 9 Melanoma 8 Sarcoma 7 Prostatic Neoplasms 7 Neoplasm Metastasis 6 Lung Neoplasms 6 Glioblastoma 6 Ovarian Neoplasms 5 Brain Neoplasms 5 Thyroid Neoplasms 4 Recurrence 4 Pancreatic Neoplasms 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myelodysplastic Syndromes 3 Multiple Myeloma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leiomyosarcoma 3 Gliosarcoma 3 Gallbladder Neoplasms 3 Carcinoma 3

Interventions

Pemetrexed 14 Cisplatin 13 pembrolizumab 4 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Radiotherapy 3 Gemcitabine 3 Carboplatin 3 cediranib 2 amatuximab 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Drug Therapy 2 Cyclophosphamide 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1 sodium thiosulfate 1 sargramostim 1 nintedanib 1 napabucasin 1 methoxyamine 1 liposomal doxorubicin 1 incomplete Freund's adjuvant 1 fresolimumab 1 durvalumab 1 defactinib 1 cixutumumab 1 bintrafusp alfa protein, human 1 bemcentinib 1 belinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡